Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niccolò Bolli

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Haematologica|July 11, 2024
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myelomaNoemi Puccio, Gloria Manzotti, Elisabetta Mereu, et al.
Blood Advances|April 7, 2022
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohortMatteo Claudio Da Vià, Marta Lionetti, Alessio Marella, et al.
Cancers|July 2, 2021
Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple MyelomaYanira Ruiz-Heredia, Alejandra Ortiz-Ruiz, Mehmet K Samur, et al.
Nature Communications|August 28, 2021
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myelomaKylee H Maclachlan, Even H Rustad, Andriy Derkach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Functional Impact of Genomic Complexity on the Transcriptome of Multiple MyelomaBachisio Ziccheddu, Matteo C Da Vià, Marta Lionetti, et al.
Hematological Oncology|July 6, 2022
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplantCirino Botta, Emilia Gigliotta, Bruno Paiva, et al.
Clinical and Translational Medicine|August 20, 2025
The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinomaGiorgia Tiberi, Alessandro Scagliotti, Claudia Curcio, et al.
Haematologica|November 9, 2014
Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocolNiccolò Bolli, Nicla Manes, Thomas McKerrell, et al.
Haematologica|October 15, 2020
<i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)Francesco Maura, Anna Dodero, Cristiana Carniti, et al.
Haematologica|July 13, 2023
<i>DIS3</i> depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplificationVanessa K Favasuli, Domenica Ronchetti, Ilaria Silvestris, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Haematologica|July 11, 2024
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myelomaNoemi Puccio, Gloria Manzotti, Elisabetta Mereu, et al.
Blood Advances|April 7, 2022
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohortMatteo Claudio Da Vià, Marta Lionetti, Alessio Marella, et al.
Cancers|July 2, 2021
Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple MyelomaYanira Ruiz-Heredia, Alejandra Ortiz-Ruiz, Mehmet K Samur, et al.
Nature Communications|August 28, 2021
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myelomaKylee H Maclachlan, Even H Rustad, Andriy Derkach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Functional Impact of Genomic Complexity on the Transcriptome of Multiple MyelomaBachisio Ziccheddu, Matteo C Da Vià, Marta Lionetti, et al.
Hematological Oncology|July 6, 2022
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplantCirino Botta, Emilia Gigliotta, Bruno Paiva, et al.
Clinical and Translational Medicine|August 20, 2025
The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinomaGiorgia Tiberi, Alessandro Scagliotti, Claudia Curcio, et al.
Haematologica|November 9, 2014
Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocolNiccolò Bolli, Nicla Manes, Thomas McKerrell, et al.
Haematologica|October 15, 2020
<i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)Francesco Maura, Anna Dodero, Cristiana Carniti, et al.
Haematologica|July 13, 2023
<i>DIS3</i> depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplificationVanessa K Favasuli, Domenica Ronchetti, Ilaria Silvestris, et al.
Pageof 9